Analyst Activity – Sanford C. Bernstein Initiates Coverage On Spark Therapeutics (NASDAQ:ONCE) With a Outperform

ME Staff
-
0

Analyst Ratings For Spark Therapeutics (NASDAQ:ONCE)

Today, Sanford C. Bernstein initiated coverage on Spark Therapeutics (NASDAQ:ONCE) with a Outperform.

There are 1 sell rating, 1 hold rating, 9 buy ratings on the stock.

The current consensus rating on Spark Therapeutics (NASDAQ:ONCE) is Buy (Score: 2.73) with a consensus target price of $71.28 per share, a potential 1.93% downside.

Some recent analyst ratings include

  • 7/27/2017-Sanford C. Bernstein initiated coverage with a Outperform rating.
  • 7/24/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 7/24/2017-Chardan Capital Reiterated Rating of Hold .
  • 6/28/2017-William Blair initiated coverage with a Outperform rating.
  • 5/10/2017-Wedbush Reiterated Rating of Underperform.
  • 4/10/2017-Stifel Nicolaus Reiterated Rating of Buy.

Recent Insider Trading Activity For Spark Therapeutics (NASDAQ:ONCE)
Spark Therapeutics (NASDAQ:ONCE) has insider ownership of 7.30% and institutional ownership of 88.94%.

  • On 7/25/2017 Katherine A High, Insider, sold 10,000 with an average share price of $72.53 per share and the total transaction amounting to $725,300.00. View SEC Filing
  • On 7/24/2017 Anand Mehra, Director, sold 211,858 with an average share price of $70.15 per share and the total transaction amounting to $14,861,838.70. View SEC Filing
  • On 7/24/2017 Daniel Faga, Insider, sold 3,000 with an average share price of $70.00 per share and the total transaction amounting to $210,000.00. View SEC Filing
  • On 7/5/2017 Jeffrey D Marrazzo, CEO, sold 5,669 with an average share price of $65.00 per share and the total transaction amounting to $368,485.00. View SEC Filing
  • On 6/29/2017 Daniel Faga, Insider, sold 4,500 with an average share price of $62.71 per share and the total transaction amounting to $282,195.00. View SEC Filing
  • On 6/27/2017 Katherine A High, Insider, sold 10,000 with an average share price of $60.96 per share and the total transaction amounting to $609,600.00. View SEC Filing
  • On 6/21/2017 Anand Mehra, Director, sold 6,302 with an average share price of $65.00 per share and the total transaction amounting to $409,630.00. View SEC Filing

Recent Trading Activity for Spark Therapeutics (NASDAQ:ONCE)
Shares of Spark Therapeutics closed the previous trading session at 73.51 up +0.83 1.14% with 243,876 shares trading hands.